Viral hepatitis is a silent epidemic. According to the United States Department of Health and Human Services, it is estimated that 2.7 to 3.9 million persons are infected with the hepatitis C virus (HCV) in the United States alone. An enormous public health danger lies in the fact that many infected patients are unaware of their diseased state. HCV's slow disease progression can lead to liver cirrhosis or hepatocellular carcinoma, which ultimately requires transplantation or causes mortality.
Up-to-date guidance for the treatment of HCV infection from IDSA and the American Association for the Study of Liver Diseases, in collaboration with the International Antiviral Society-USA.
IDSA offers a Maintenance of Certification module specific to Hepatitis C.
- HCV Clinical Guidance - Additional Information
- 2012 Update on the Management and Treatment of Hepatitis C Virus Infection
Management of Hepatitis C
- AASLD Guideline: Management of Hepatocellular Carcinoma (PDF)
- Management and Treatment of Patients with Cirrhosis and Portal Hypertension Review (PDF)
- HCV Management - Additional Information
- HCV Screening Letter
- HCV Rx Appeal Letter Template